These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 32448257
1. A cluster-randomized, non-inferiority trial comparing use of misoprostol for universal prophylaxis vs. secondary prevention of postpartum hemorrhage among community level births in Egypt. Anger HA, Dabash R, Hassanein N, Darwish E, Ramadan MC, Nawar M, Charles D, Breebaart M, Winikoff B. BMC Pregnancy Childbirth; 2020 May 24; 20(1):317. PubMed ID: 32448257 [Abstract] [Full Text] [Related]
2. Testing a home-based model of care using misoprostol for prevention and treatment of postpartum hemorrhage: results from a randomized placebo-controlled trial conducted in Badakhshan province, Afghanistan. Abbas DF, Mirzazada S, Durocher J, Pamiri S, Byrne ME, Winikoff B. Reprod Health; 2020 Jun 05; 17(1):88. PubMed ID: 32503556 [Abstract] [Full Text] [Related]
3. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial. Atukunda EC, Siedner MJ, Obua C, Mugyenyi GR, Twagirumukiza M, Agaba AG. PLoS Med; 2014 Nov 05; 11(11):e1001752. PubMed ID: 25369200 [Abstract] [Full Text] [Related]
5. Using Misoprostol for Primary versus Secondary Prevention of Postpartum Haemorrhage - Do Costs Matter? Chatterjee S, Sarkar A, Rao KD. PLoS One; 2016 Nov 05; 11(10):e0164718. PubMed ID: 27755601 [Abstract] [Full Text] [Related]
6. Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan. Zuberi NF, Durocher J, Sikander R, Baber N, Blum J, Walraven G. BMC Pregnancy Childbirth; 2008 Aug 21; 8():40. PubMed ID: 18718007 [Abstract] [Full Text] [Related]
8. Oral misoprostol for preventing postpartum haemorrhage in home births in rural Bangladesh: how effective is it? Hashima-E-Nasreen, Nahar S, Al Mamun M, Afsana K, Byass P. Glob Health Action; 2011 Aug 21; 4():. PubMed ID: 21845143 [Abstract] [Full Text] [Related]
11. A double-blind, randomized controlled trial to explore oral tranexamic acid as adjunct for the treatment for postpartum hemorrhage. Diop A, Abbas D, Ngoc NTN, Martin R, Razafi A, Tuyet HTD, Winikoff B. Reprod Health; 2020 Mar 06; 17(1):34. PubMed ID: 32143721 [Abstract] [Full Text] [Related]
12. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women. Chaudhuri P, Biswas J, Mandal A. Int J Gynaecol Obstet; 2012 Feb 06; 116(2):138-42. PubMed ID: 22100204 [Abstract] [Full Text] [Related]
13. The efficacy of intrauterine misoprostol during cesarean section in prevention of primary PPH, a randomized controlled trial. Alalfy M, Lasheen Y, Elshenoufy H, Elzahaby IM, Kaleem HW, El Sawah H, Azkalani A, Saber W, Rashwan ASSA. J Matern Fetal Neonatal Med; 2020 May 06; 33(9):1459-1465. PubMed ID: 30176758 [Abstract] [Full Text] [Related]
15. Misoprostol for the management of postpartum bleeding: a new approach. Dabash R, Blum J, Raghavan S, Anger H, Winikoff B. Int J Gynaecol Obstet; 2012 Dec 06; 119(3):210-2. PubMed ID: 22980431 [Abstract] [Full Text] [Related]
19. Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India. Chandhiok N, Dhillon BS, Datey S, Mathur A, Saxena NC. Int J Gynaecol Obstet; 2006 Feb 06; 92(2):170-5. PubMed ID: 16371228 [Abstract] [Full Text] [Related]